Acetylon Pharmaceuticals To Present At BioPharm America 2015

BOSTON--(BUSINESS WIRE)--Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase (HDAC) inhibitors for enhanced therapeutic outcomes, today announced that Walter Ogier, President and Chief Executive Officer, will present at the 8th Annual BioPharm America conference, taking place September 15-17, 2015, in Boston, MA. Mr. Ogier will provide an overview on the Company’s pipeline of selective HDAC inhibitors in multiple myeloma, lymphoma and other disorders on Wednesday, September 16, 2015, at 11:45am EDT in the Wellesley room on Level 3.

Help employers find you! Check out all the jobs and post your resume.